807 filings
424B3
KZIA
Kazia Therapeutics Limited
27 Mar 24
Prospectus supplement
8:37am
6-K
KZIA
Kazia Therapeutics Limited
27 Mar 24
Current report (foreign)
8:26am
6-K
KZIA
Kazia Therapeutics Limited
26 Mar 24
Current report (foreign)
8:02am
424B3
KZIA
Kazia Therapeutics Limited
21 Feb 24
Prospectus supplement
4:19pm
6-K
KZIA
Kazia Therapeutics Limited
21 Feb 24
Kazia Therapeutics Reports Early Conclusion of Clinical Trial After Reaching Primary Endpoint
9:19am
EFFECT
qelu ykj80e6yr0w
6 Feb 24
Notice of effectiveness
12:15am
424B3
h8du2 fsc5ovdonewrs
5 Feb 24
Prospectus supplement
4:19pm
CORRESP
hbw w88jp7tdj83lk70b
2 Feb 24
Correspondence with SEC
12:00am
UPLOAD
t5jmuj
1 Feb 24
Letter from SEC
12:00am
F-1
vn6qt
31 Jan 24
Registration statement (foreign)
12:00am
6-K
pktnv h9x
18 Jan 24
Current report (foreign)
4:30pm
6-K
6jq4x6
12 Jan 24
Current report (foreign)
4:05pm
EFFECT
m0jedsgeg ppkl16u0z
26 Dec 23
Notice of effectiveness
12:15am
CORRESP
eh57r
21 Dec 23
Correspondence with SEC
12:00am
UPLOAD
p4bh7wvrtui 9b61bj7f
20 Dec 23
Letter from SEC
12:00am
F-3
oyihne
15 Dec 23
Shelf registration (foreign)
5:26pm
D
eqrcqr3s
15 Dec 23
$2.00 mm in options / securities to be acquired, sold $2.00 mm, 1 investor
4:49pm
6-K
5s1cxo
6 Dec 23
Kazia Therapeutics Announces Closing of $2 Million Registered Direct Offering
8:31am
424B5
ctg bc0lby
4 Dec 23
Prospectus supplement for primary offering
4:05pm
6-K
jylz0p3w
1 Dec 23
Kazia Therapeutics Announces $2 Million Registered Direct Offering
8:30am